Fibrin gel improves the survival of transplanted myoblasts

Cell Transplantation

Volumn 21, Issue 1, 2012, Pages 127-137

  Gerard, Catherine ^a   Forest, Marie Anne ^a   Beauregard, Genevieve ^a   Skuk, Daniel ^a   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Cell survival; Cell transplantation; Duchenne muscular dystrophy (DMD); Fibrin gel; Graft success

Indexed keywords

DYSTROPHIN; FIBRIN; FIBRINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOIKIS; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EXTRACELLULAR MATRIX; GEL; HUMAN; HUMAN CELL; MALE; MUSCLE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL;

ADULT; ANIMALS; ANOIKIS; CELL ADHESION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; DYSTROPHIN; FIBRIN; GELS; GRAFT SURVIVAL; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE FIBERS, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MYOBLASTS; YOUNG ADULT;

MUS;

EID: 84858132890     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X576018     Document Type: Article

References (36)

1. Ahmed, T. A.; Dare, E. V.; Hincke, M. Fibrin: A versatile scaffold for tissue engineering applications. Tissue Eng. Part B Rev. 14(2):199-215; 2008.
2. Bach, A. D.; Arkudas, A.; Tjiawi, J.; Polykandriotis, E.; Kneser, U.; Horch, R. E.; Beier, J. P. A new approach to tissue engineering of vascularized skeletal muscle. J. Cell. Mol. Med. 10(3):716-726; 2006.
3. Beauchamp, J. R.; Morgan, J. E.; Pagel, C. N.; Partridge, T. A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144(6):1113-1122; 1999.
4. Beauchamp, J. R.; Pagel, C. N.; Partridge, T. A. A dualmarker system for quantitative studies of myoblast transplantation in the mouse. Transplantation 63(12): 1794-1797; 1997.
5. Beier, J. P.; Stern-Straeter, J.; Foerster, V. T.; Kneser, U.; Stark, G. B.; Bach, A. D. Tissue engineering of injectable muscle: Three-dimensional myoblast-fibrin injection in the syngeneic rat animal model. Plast. Reconstr. Surg. 118(5):1113-1121; 2006.
6. Benabdallah, B. F.; Bouchentouf, M.; Rousseau, J.; Bigey, P.; Michaud, A.; Chapdelaine, P.; Scherman, D.; Tremblay, J. P. Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice. Cell Transplant. 17(3):337-350; 2008.
7. Benabdallah, B. F.; Bouchentouf, M.; Rousseau, J.; Tremblay, J. P. Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice. Cell Transplant. 18(7):709-718; 2009.
8. Bian, W.; Bursac, N. Engineered skeletal muscle tissue networks with controllable architecture. Biomaterials 30(7):1401-1412; 2008.
9. Birla, R. K.; Borschel, G. H.; Dennis, R. G.; Brown, D. L. Myocardial engineering in vivo: Formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng. 11(5-6):803-813; 2005.
10. Bonilla, E.; Sarmitt, C. E.; Miranda, A. F.; Hays, A. P.; Salviati, G.; DiMauro, S.; Kunkel, L. M.; Hoffman, E. P.; Rowland, L. P. Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface. Cell 54(4):447-452; 1988.
11. Boontheekul, T.; Hill, E. E.; Kong, H. J.; Mooney, D. J. Regulating myoblast phenotype through controlled gel stiffness and degradation. Tissue Eng. 13(7):1431-1442; 2007.
12. Bouchentouf, M.; Benabdallah, B. F.; Bigey, P.; Yau, T. M.; Scherman, D.; Tremblay, J. P. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther. 15(6):404-414; 2008.
13. Bouchentouf, M.; Benabdallah, B. F.; Rousseau, J.; Schwartz, L. M.; Tremblay, J. P. Induction of Anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways. Am. J. Transplant. 7(6):1491-1505; 2007.
14. Bouchentouf, M.; Benabdallah, B. F.; Tremblay, J. P. Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation 77(9):1349-1356; 2004.
15. Chakkalakal, J. V.; Thompson, J.; Parks, R. J.; Jasmin, B. J. Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies. FASEB J. 19(8):880-891; 2005.
16. Christman, K. L.; Vardanian, A. J.; Fang, Q.; Sievers, R. E.; Fok, H. H.; Lee, R. J. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44(3):654-660; 2004.
17. Farini, A.; Razini, P.; Erratico, S.; Torrente, Y.; Meregalli, M. Cell based therapy for Duchenne muscular dystrophy. J. Cell. Physiol. 221(3):526-534; 2009.
18. Frisch, S. M.; Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124(4): 619-626; 1994.
19. Gerard, C.; Blouin, K.; Tchernof, A.; Doillon, C. J. Adipogenesis in nonadherent and adherent bone marrow stem cells grown in fibrin gel and in the presence of adult plasma. Cells Tissues Organs 187(3):186-198; 2008.
20. Grossmann, J. Molecular mechanisms of "detachmentinduced apoptosis-anoikis". Apoptosis 7(3):247-260; 2002.
21. Haider, H. K.; Ashraf, M. Preconditioning and stem cell survival. J. Cardiovasc. Transl. Res. 3(2):89-102; 2010.
22. Haider, K. H.; Idris, N. M.; Kim, H. W.; Ahmed, R. P.; Shujia, J.; Ashraf, M. MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in pre-conditioning of skeletal myoblasts. Cardiovasc. Res. 88(1):168-178; 2010.
23. Hecker, L.; Khait, L.; Radnoti, D.; Birla, R. Development of a microperfusion system for the culture of bioengineering heart muscle. ASAIO J. 54(3):284-294; 2008.
24. Huang, Y.; Dennis, R. G.; Larkin, L.; Baar, K. Rapid formation of functional muscle in vitro using fibrin gels. J. Appl. Physiol. 98(2):706-713; 2005.
25. Jeon, O.; Ryu, S. H.; Chung, J. H.; Kim, B. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J. Control. Release 20:249-259; 2005.
26. Kinoshita, I.; Vilquin, J. T.; Tremblay, J. P. Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice. Muscle Nerve 18:834-841; 1995.
27. Koning, M.; Harmsen, M. C.; van Luyn, M. J. A.; Werker, P. M. N. Current opportunities and challenges in skeletal muscle tissue engineering. J. Tissue Eng. Regen. Med. 3: 407-415; 2009.
28. Laflamme, M. A.; Chen, K. Y.; Naumova, A. V.; Muskheli, V.; Fugate, J. A.; Dupras, S. K.; Reinecke, H.; Xu, C.; Hassanipour, M.; Police, S.; O'Sullivan, C.; Collins, L.; Chen, Y.; Minami, E.; Gill, E. A.; Ueno, S.; Yuan, C.; Gold, J.; Murry, C. E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25:1015-1024; 2007.
29. Lafreniere, J. F.; Caron, M. C.; Skuk, D.; Goulet, M.; Cheikh, A. R.; Tremblay, J. P. Growth factor coinjection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success. Cell Transplant. 18:719-730; 2009.
30. Martens, T. P.; Godier, A. F. G.; Parks, J. J.; Wan, L. Q.; Koeckert, M. S.; Eng, G. M.; Hudson, B. I.; Sherman, W.; Vunjak-Novakovic, G. Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant. 18:297-304; 2009.
31. Mendell, J. R.; Kissel, J. T.; Amato, A. A.; King, W.; Signore, L.; Prior, T. W.; Sahenk, Z.; Benson, S.; McAudrew, P. E.; Rice, R. Myoblast transfert in the treat-ment of Duchenne5s muscular dystrophy. N. Engl. J. Med. 333(13):832-838; 1995.
32. Skuk, D.; Caron, N. J.; Goulet, M.; Roy, B.; Tremblay, J. P. Resetting the problem of cell death following musclederived cell transplantation: Detection, dynamics and mechanisms. J. Neuropathol. Exp. Neurol. 62(9):951-967; 2003.
33. Skuk, D.; Tremblay, J. P. "Engineering" myoblast transplantation. Graft 4:558-570; 2001.
34. Song, H.; Song, B. W.; Cha, M. J.; Choi, I. G.; Hwang, K. C. Modification of mesenchymal stem cells for cardiac regeneration. Expert Opin. Biol. Ther. 10(3):309-319; 2010.
35. Tedesco, F. S.; Dellavalle, A.; Diaz-Manera, J.; Messina, G.; Cossu, G. Repairing skeletal muscle: Regenerative potential of skeletal muscle stem cells. J. Clin. Invest. 120: 11-19; 2010.
36. Yanagiuchi, A.; Miyake, H.; Nomi, M.; Takenaka, A.; Fujisawa, M. Modulation of the microenvironment by growth factors regulates the in vivo growth of skeletal myoblasts. BJU Int. 103(11):1569-1573; 2009.